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MiR-424 Promotes Non-Small Cell Lung Cancer Progression and Metastasis through Regulating the Tumor Suppressor Gene TNFAIP1

Introduction
Lung cancer is a worldwide common malignancy which arises from lung tissue and has become one of the most common factor leading to human deaths [1] . Statistics show that morbidity for lung cancer is high and the 5-year survival rate for lung cancer is approximately 14% [2] . Non-small cell lung cancer (NSCLC) and small cell lung cancer are the two types for lung cancer based on the histological characteristics, in which NSCLC accounts for about 80% of lung cancer [3] . Although many treatment methods including immune or medication therapy, surgery and genetic therapy play crucial roles in NSCLC treatment [4, 5] , the cure results still remain unsatisfactory due to the unknown complicate pathogenesis of NSCLC. Therefore, to explore several useful target genes for NSCLC treatment will be necessary. microRNAs (miRNAs) are endogenous 20-22 nt in length and are highly conserved noncoding RNAs that function in varieties of biological processes at the transcriptional or posttranscriptional level by targeting the 3'UTR of genes [6] . Accordingly, increasing evidence has demonstrated that various miRNAs are involved in the progression and biological of NSCLC [7] [8] [9] . For example, miR-21 promotes NSCLC invasion and chemo-Sensitivity through targeting SMAD7 [10] . miR-509-5p decreases NSCLC cells proliferation, migration and invasive capability by attenuating FOXM1 [11] . Diversity of miRNAs has become the biomarkers in lung cancer diagnosis, which is benefit from the easy detection in serum [12, 13] . In recent studies, miR-424 has been underlined in several kinds of tumors progression and development including bladder cancer and ovarian cancer [14, 15] . Additionally, Donnem et al. refers that several miRNAs including miR-424 are correlated significantly with NSCLC [16] . But although several studies have investigated the significant of miR-424 in NSCLC, few have reported the mechanism of miR-424 in NSCLC development and progression.
Tumor necrosis factor, alpha-induced protein 1 (TNFAIP1) expression can be induced by the tumor necrosis factor alpha in umbilical vein endothelial cells [17] . Pivotal tumor suppressor roles of TNFAIP1 have been implicated in variety of diseases, including anorexia nervosa, and paclitaxel resistance [18, 19] . In addition, roles of TNFAIP1 mutation in tumor progression and development have been illustrated, such as in breast cancer [20] . Also, Zhou et al. reports that miR-372 functions as an oncogene in gastric carcinoma via targeting TNFAIP1 [21] . Similarly, Cui et al. demonstrates that miR-224 promotes NSCLC tumor progression through targeting TNFAIP1 and Smad4 [22] .
In this study, we analyzed the potential effects of miR-424 expression on NSCLC cells proliferation and metastasis using A549 and H1975 cells, and siRNA-mediated gene silencing. Further deep experimental methods were used to assess the effects of miR-424 suppression on NSCLC cell invasion, migration and proliferation through targeting TNFAIP1. This study aimed to investigate the possible roles of miR-424 in NSCLC metastasis and to illustrate its potential mechanism.
Materials and Methods
Cell culture
Human lung adenocarcinoma cell lines A549 and H1975 were both purchased from Cell Bank of the Chinese Academy of Sciences (Shanghai, China), and were cultured in RPMI-1640 media (Gibco-BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; Gibco-BRL), 100 U/mL penicillin, 100 μg/mL streptomycin (Sigma-Aldrich, St. Louis, MO) and 1% L-glutamine (Invitrogen, Gaithersburg, MD) at 37°C with 5% CO 2 .
Treatment with hsa-miR-424 mimic or inhibitor
Cells were planted on 60-mm dish and after 24 h of incubation, cells were treated with Lipofectamine® RNAiMAX Transfection Reagent (3 μL per 1 mL media, Life Technologies, Gaithersburg, MD) and mimic or inhibitor in Opti-MEM® I Reduced Serum Medium (Life Technologies) [22] . After 48 h transfection, the cells were prepared for further analysis.
qRT-PCR
Total mRNA was isolated from cells with Trizol (Invitrogen) according to the manusfactuer's protocol. The isolated RNA was treated with RNase-free DNase I (Promega Biotech, Madison, WI) to remove the mixed DNA. Consequently, concentration and purity of isolated RNA were measured with SMA 400 UV-VIS (Merinton, Shanghai, China). Purified RNA was used for cDNA synthesis with the PrimerScript 1st Strand cDNA Synthesis Kit (Invitrogen). Expressions of targets were detected in an Eppendorf Mastercycler (Brinkman Instruments, Westbury, NY) using the SYBR ExScript RT-qPCR Kit (Takara, Dalian, China). The total reaction system of 20 μL volume was as follows: 1 μL cDNA from the above PCR, 10 μL SYBR Premix EX Taq, 1 μL each of the primers (10 μM), and 7 μL ddH 2 O. The PCR program was as follows: denaturation at 50°C for 2 min; 95°C for 10 min; followed by 45 cycles of 95°C for 10 s, and 60°C for 1 min. Melting curve analysis of amplification products was performed at the end of each PCR to confirm that only one product was amplified and detected. Phosphoglyceraldehyde dehydrogenase (GAPDH) was chosen as the internal control. Primers used for targets amplification were as follows: miR-424 sense: 5'-AGC AGC AAT TCA TGT TTT GAA G-3', antisense: 5'-GCA GCG CCT CAC GTT TT-3', and TNFAIP1 sense: 5'-ATA GAC ACG GAT TAC CCA CC-3', antisense: 5'-CAG GCT TTG CTC AAT GC-3'.
Western blotting A total of 50 μg protein (per lane) were separated onto a 10% sodium dodecyl sulfate (SDS)-polyacrylamide gel and blotted onto polyvinylidene fluoride (PVDF) membranes. The membrane was blocked in PBST (0.1% Tween in PBS) and probed with primary antibodies (1:1,000 for TNFAIP1 and 1:5,000 for GAPDH, Sigma-Aldrich) at 4°C overnight. The membranes were then incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies (1:1,000 dilution). The immunoreactive protein bands were developed by enhanced chemiluminescence. The immunoreactive bands were analyzed by a densitometer. Luciferase assay Cells in 24-well plates were transfected with TNFAIP1-luc (SABiosciences) along with various expression plasmids, using the Lipofectamine transfection reagent (Invitrogen). Transfected cells were lysed, and the luciferase activities in the cell lysates were analyzed using a Luciferase Reporter assay kit (Promega). Luciferase activity was measured as relative light units using a luminometer (Turner Designs, Sunnyvale, CA). The injected mice were kept in a specific pathogen-free environment and the day when tumor was firstly grossly visible was recorded, and the tumor size was measured and recorded every 2 weeks thereafter. When tumor was grown at about 3 months, the tumor was taken out and measured in vitro for the comparison of tumor size. Tumor volume was calculated as length × width 2 /2, where the length and width are the longest and shortest axes in millimeters [23] .
Tumor growth in nude mice
Statistical analysis
All experiments were repeated three times. The results of multiple experiments are presented as the mean ± SD. Data were analyzed by SPSS 19.0 statistical software (SPSS Inc., Chicago, IL, USA) using Student's t test or one-way analysis of variance (ANOVA) as appropriate. The P<0.05 was considered to indicate a statistically significant result.
Results
miR-424 expression promotes A549 cells migration and invasion
Compared to the controls, the migrated cells were significantly increased when cells were transfected with miR-424 mimic (P < 0.05), but the migrated cells in inhibitor group were approximately to control group and there was no significant difference between two groups ( Fig. 1A and 1B) . Similarly, miR-424 mimic transfection significantly increased invasive A549 cells than that in control and in inhibitor group (P < 0.05, Fig. 1C and 1D) . 
miR-424 promotes A549 cells proliferation and colony formation
When A549 cells were transfected with miR-424 mimic, the expression level of miR-424 was assessed, and the results revealed that miR-424 was highly expressed while it was lowly expressed by the inhibitor transfection (P < 0.05, Fig. 2A ). The cell viability was significantly increased compared to the control group (P < 0.05, Fig. 2B ), indicating miR-424 overexpression increased A549 cells viability. Colony formation assay was conducted to further test the effects of miR-424 expression on A549 cells proliferation. Overexpression of miR-424 significantly increased the colonies compared to the control group (P < 0.05, Fig.  2C and 2D) .
miR-424 regulates the target gene TNFAIP1 expression in A549 cells
By using bioinformatics analysis we found that TNFAIP1 was the target gene for miR-424, and there were two regulatory sites on TNFAIP1 3'-UTR (Fig. 3A) . Luciferase assay was conducted to further verify whether TNFAIP1 gene was the target for miR-424. When miR-424 and target gene promoter sequence were co-transfected into A549 cells, the relative luciferase activity and expression level of TNFAIP1 were both significantly decreased compared to the control group (P < 0.05). In contrast, when cells were added with miR-424 inhibitor, the two indexes including relative luciferase activity and expression level were significantly increased compared with the control group (P < 0.05 or P < 0.01) (Fig. 3B and  3C ), indicating that miR-424 could negatively regulate TNFAIP1 expression in A549 cells.
miR-424 promotes cell migration and invasion in TNFAIP1 silenced A549 cells
The target gene TNFAIP1 was silenced in A549 cells to further investigate the effects of miR-424 on A549 cells migration and proliferation (Fig. 4A-4C ). When target gene TNFAIP1 was silenced in A549 cells, the migrated and invasive cells, as well as the colony number were all significantly increased compared to the control (P < 0.05), indicating TNFAIP1 was the tumor suppressor for lung cancer. Accordingly, when TNFAIP1 silenced A549 cells A549 cells viability was significantly increased when cells were transfected with miR-424; C-D: when cells were transfected with miR-424, the colonies were more than that in control, but colony number in Inhibitor group was almost similar to the control group. *: P < 0.05; **: P < 0.01 compared to the control.
Fig. 3. Prediction of target gene for miR-424 in A549 cells A:
bioinformatics analysis showed that there were two regulatory sites on TNFAIP1 3'-UTR for miR-424; B: Luciferase assay performed that TNFAIP1 was negatively regulated by miR-424 in A549 cells, but this negative regulation was reversed by miR-424 inhibitor; C: qRT-PCR analysis and western blotting showed that TNFAIP1 level was down-regulated by miR-424. *: P < 0.05; **: P < 0.01 compared to the control. 424 inhibitor application was in reverse conducted to further assess miR-424 expression on A549 cells migration and invasion. Data showed that there was no significant difference when compared to the control group.
miR-424 promotes cell migration and invasion in TNFAIP1 silenced H1975 cells
To investigate whether the migration-and invasion-promoting effects of miR-424 are not limited to A549 cells, another human lung adenocarcinoma cell line H1975 was used. As results shown in Fig. 5A and 5B, the number of migrated cells and invasive cells were both Transwell assay showed that the migrated and invasive cells number were both increased when cells were transfected with miR-424 mimic than that in control, however, they were both reduced when cells were transfected with miR-424 inhibitor. *: P < 0.05 compared to the control. increased after miR-424 mimic transfection (P < 0.05), this was confirmed with the findings from A549 cells. However, unlike with A549 cells, migrated and invasive cells number were reduced after miR-424 inhibitor transfection (P < 0.05).
Further, we asked if TNFAIP1 also involved in miR-424-mediated H1975 cells. As results shown in Fig. 6A and 6B, in H1975 cells, TNFAIP1 gene was the target for miR-424 (P < 0.05) and it was negatively regulated by miR-424 (P < 0.05 or P < 0.01). Next, we knocked down TNFAIP1 expression in H1975 cells by transfection with TNFAIP1 targeted siRNA, and we found that TNFAIP1 silence improved cell migration and invasion (P < 0.05, Fig. 6C and 6D) . Cell migration and invasion abilities were highly increased when cells were co-transfected with TNFAIP1 siRNA and miR-424 mimic (P < 0.01). However, miR-424 suppression abolished TNFAIP1 silence-induced increases in cell migration and invasion, as no significant difference was found between si-TNFAIP1+inhibitor group and control group.
miR-424 promotes tumor growth by regulating TNFAIP1 in rat
To further verify the correlation between miR-424 and TNFAIP1 on tumor cell growth, we therefore analyzed the tumor size in mice by subcutaneous injection with miR-424 and TNFAIP1 modified A549 cells (Fig. 7A-7C) . The results revealed that tumor size in mice injected with TNFAIP1 silencing-cells was larger than that in control mice (P < 0.05 or P < 0.01), whereas the tumor in mice injected with TNFAIP1 silencing-and miR-424 overexpressing-cells was even more lager in comparison with the control group (P < 0.001). However, when mouse was injected with the TNFAIP1 silencing-and miR-424 suppressingcells, the tumor size was approximately to that in control. These results revealed that miR-424 could regulate tumor growth by targeting TNFAIP1 at another angle.
Discussion
Increasing evidence has demonstrated that miRNAs play crucial roles in NSCLC biology, and miR-424 is up-regulated in NSCLC development [12, 16, 24] . To date, miR-424 alterations have been reported to be involved in various diseases including cancer, pulmonary arterial hypertension, and acute myeloid leukemia [16, 25, 26] . In this study, we investigated the role of miR-424 expression in NSCLC metastasis and progression. Our results showed that overexpression of miR-424 significantly increased the cell proliferation, migration and invasion, but these effects were reversed by miR-424 inhibitor application. In addition, TNFAIP1 was the target gene for miR-424 in NSCLC progression, and was negatively regulated by miR-424. Moreover, when TNFAIP1 was silenced, the migrated and invasive Fig. 7 . Effects of miR-424 expression on the tumor formation in rat. A-C: The size of tumor in mice injected with TNFAIP1 silencing-A549 cells was larger than that in control group, while it was even larger in mice injected with TNFAIP1 silencing-and miR-424 overexpressing-cells compared to the control group. However, the tumor size in mice injected with TNFAIP1 silencing-and miR-424 suppressing-cells was almost the same size as that in the control. *: P < 0.05; **: P < 0.01; ***: P < 0.001 compared to the control. cells were drastically increased by miR-424 overexpression.
Abundant evidences have demonstrated that cell migration and invasion are the major factors involving in tumor metastasis, as well as cell proliferation in tumor development and progression [27, 28] . Nakashima et al. demonstrated that down-regulation of miR-424 played pivotal roles in senile hemangioma therapy via promoting angiogenesis through cyclin E1 and MEK1 [29] . Donnem et al. proved that miR-424 was up-regulated in NSCLC tissue [16] . Few reports have mentioned the effects of miR-424 expression in lung cancer metastasis. However, miR-424 played crucial roles in osteosarcoma cells migration and invasion through targeting fatty acid synthase [30] . Besides, miR-424 is an contributor for prostate cancer metastasis via involving in biological including migration and invasion [31] . Our study showed that the migrated and invasive lung cancer cells, as well as the colonies were significantly increased when cells were transfected with miR-424 expressing vector, indicating that miR-424 overexpression may closely correlated with NSCLC metastasis and progression.
It is well-known that miRNAs play crucial roles in diseases development through targeting the 3'-UTR of genes. Based on the reviewing work on previous studies, we confirmed that the tumor suppressor gene TNFAIP1 was the target for miR-424 in NSCLC. Rossi et al. proved that TNFAIP1 is an ultraconserved gene which is involving in lung cancer [32] . Meanwhile, luciferase assay showed that miR-424 negatively regulated TNFAIP1 expression in A549 and H1975 cells. Recently, Zhang and his colleagues demonstrated that miR-181a regulated pancreatic cancer growth and migration through interacting with TNFAIP1 [33] , while Zhou et al. proved that TNFAIP1 can be directly targeted by miR-372 in gastric carcinogenesis [34] . In addition, it has been said that TNFAIP1 is the target gene for miR-224 in NSCLC invasion and growth [22] . In addition, the in vitro animal study also showed the tumor size was larger by the miR-424 mimic and silenced TNFAIP1 transfection than the other groups, suggesting the promoting effect of miR-424 on tumor growth by regulating TNFAIP1. Based on our results, we speculated that miR-424 may be a contributor for NSCLC metastasis and growth through inhibiting the expression of tumor suppressor gene TNFAIP1.
Furthermore, TNFAIP1 was silenced using gene silencing method to assess the negatively regulatory effects of miR-424 on TNFAIP1. TNFAIP1 is a tumor suppressor in lung cancer through involving in DNA synthesis and apoptosis [35] . Also, TNFAIP1 was interacted with miR-181a and then involved in proliferation and migration of pancreatic cancer [33] . In this study, when TNFAIP1 was silenced, the migrated and invasive cells were significantly increased compared to that in control group, suggesting the tumor suppressive role of TNFAIP1 in lung cancer. Meanwhile, Nakshima and his colleagues proved that downregulation of miR-424 enhanced the abnormal angiogenesis through cyclin E1 in senile hemangioma [29] . Additionally, TNFAIP1 can be directly targeted by miR-224 and then participated in NSCLC migration and progression [22] . In agreement with previous data, our data showed that number of migrated and invasive cells were drastically increased when miR-424 was up-regulated, implying the in vitro miR-424 application would enhance NSCLC cells metastasis and growth at the condition of TNFAIP1 was silenced, which in reverse demonstrated the negatively regulatory effects of miR-424 on TNFAIP1, as well as its effects on tumor cells metastasis and growth.
In conclusion, the data presented herein suggest that miR-424 overexpression increases lung cancer progression and metastasis through involving in cell proliferation, migration and invasion by suppressing TNFAIP1 gene. The mechanisms revealed in our study may loan theoretical basis for the possible application of miR-424 in NSCLC target therapeutic treatment.
